drugset / Trial / NCT01149005

Cystic Fibrosis (CF) Exacerbation and Insulin Treatment

NCT01149005

Unknown 30 enrolled Hadassah Medical Organization
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate whether insulin treatment during pulmonary exacerbation (PE) in patients with Cystic Fibrosis (CF)and normoglycemia improves their short term outcome by normalizing the glycemic profile and enhancing recovery. the investigators would like to evaluate whether insulin treatment during exacerbation improves both the general clinical condition of these patients and also has a protecting effect on ß-cells by preventing the deleterious effect of "chronic" hyperglycemia.

Timeline

Start
2010-06
Primary completion
2015-06
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic 1 iu Subcutaneous
Subject Insulin Lispro Protein / enzyme biologic 4 iu Subcutaneous
Subject insulin aspart Protein / enzyme biologic 1 iu Subcutaneous
Subject insulin aspart Protein / enzyme biologic 4 iu Subcutaneous